{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:51:55Z","timestamp":1770364315588,"version":"3.49.0"},"reference-count":53,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"DOI":"10.31744\/einstein_journal\/2026ao1770","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:41:29Z","timestamp":1770309689000},"source":"Crossref","is-referenced-by-count":0,"title":["Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue"],"prefix":"10.31744","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4506-7641","authenticated-orcid":false,"given":"Luiza Wolf","family":"Zanardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1180-5053","authenticated-orcid":false,"given":"Larissa dos Santos","family":"Izabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4803-3869","authenticated-orcid":false,"given":"Let\u00edcia Miho","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7027-4453","authenticated-orcid":false,"given":"Marcela Botelho de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1632-1250","authenticated-orcid":false,"given":"Pedro Afonso Grandino Oliveira e","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8826-8948","authenticated-orcid":false,"given":"Henrique Dametto Giroud","family":"Joaquim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6664-1252","authenticated-orcid":false,"given":"Sergio","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4769-0806","authenticated-orcid":false,"given":"William Tadeu","family":"Festuccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-724X","authenticated-orcid":false,"given":"Juliana","family":"Magdalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"issue":"1","key":"key20260205164123_B1","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","unstructured":"1 Deeks SG, Overbaugh J, Phillips A, Buchbinder S. HIV infection. Nat Rev Dis Primers. 2015;1(1):15035.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"key20260205164123_B2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.37201\/req\/083.2021","article-title":"Past and future of HIV infection. A document based on expert opinion","volume":"35","author":"Bouza","year":"2022","unstructured":"2 Bouza E, Arribas JR, Alejos B, Bernardino JI, Coiras M, Coll P, et al. Past and future of HIV infection. A document based on expert opinion. Rev Esp Quimioter. 2022;35(2):131-56.","journal-title":"Rev Esp Quimioter"},{"issue":"6205","key":"key20260205164123_B3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.1256739","article-title":"HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations","volume":"346","author":"Faria","year":"2014","unstructured":"3 Faria NR, Rambaut A, Suchard MA, Baele G, Bedford T, Ward MJ, et al. HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations. Science. 2014;346(6205):56-61.","journal-title":"Science"},{"key":"key20260205164123_B4","volume-title":"The Urgency of Now: AIDS at a Crossroads","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2024","unstructured":"4 Joint United Nations Programme on HIV\/AIDS (UNAIDS). The Urgency of Now: AIDS at a Crossroads. Geneva; 2024. Available from: http:\/\/www.wipo.int\/"},{"issue":"1","key":"key20260205164123_B5","first-page":"44","article-title":"A brief history of antiretroviral therapy of HIV infection: success and challenges","volume":"47","author":"Palmisano","year":"2011","unstructured":"5 Palmisano L, Vella S. A brief history of antiretroviral therapy of HIV infection: success and challenges. Ann Ist Super Sanita. 2011;47(1):44-8.","journal-title":"Ann Ist Super Sanita"},{"issue":"1","key":"key20260205164123_B6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","article-title":"HIV and antiretroviral therapy-related fat alterations","volume":"6","author":"Koethe","year":"2020","unstructured":"6 Koethe JR, Lagathu C, Lake JE, Domingo P, Calmy A, Falutz J, et al. HIV and antiretroviral therapy-related fat alterations. Nat Rev Dis Primers. 2020; 6(1):48.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"key20260205164123_B7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy Syndromes","volume":"45","author":"Hussain","year":"2016","unstructured":"7 Hussain I, Garg A. Lipodystrophy Syndromes. Endocrinol Metab Clin North Am. 2016;45(4):783-97.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"key20260205164123_B8","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/QAD.0b013e32834884e6","article-title":"Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection","volume":"25","author":"Scherzer","year":"2011","unstructured":"8 Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, Bacchetti P, Shlipak MG, Grunfeld C; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection. AIDS. 2011;25(11):1405-14.","journal-title":"AIDS"},{"issue":"8","key":"key20260205164123_B9","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Antiretroviral Therapy Cohort Collaboration","year":"2017","unstructured":"9 Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349-56.","journal-title":"Lancet HIV"},{"issue":"3","key":"key20260205164123_B10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/QAD.0000000000003128","article-title":"The shifting age distribution of people with HIV using antiretroviral therapy in the United States","volume":"36","author":"Althoff","year":"2022","unstructured":"10 Althoff KN, Stewart CN, Humes E, Zhang J, Gerace L, Boyd CM, et al. The shifting age distribution of people with HIV using antiretroviral therapy in the United States. AIDS. 2022;36(3):459-71.","journal-title":"AIDS"},{"key":"key20260205164123_B11","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25986","article-title":"Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France","volume":"25","author":"Marty","year":"2022","unstructured":"11 Marty L, Diawara Y, Rachas A, Grabar S, Costagliola D, Supervie V. Projection of age of individuals living with HIV and time since ART initiation in 2030: estimates for France. J Int AIDS Soc. 2022;25(Suppl 4 Suppl 4):e25986.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"key20260205164123_B12","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1016\/S2352-3018(23)00272-2","article-title":"Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies","volume":"11","author":"Trickey","year":"2024","unstructured":"12 Trickey A, McGinnis K, Gill MJ, Abgrall S, Berenguer J, Wyen C, et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV. 2024;11(3):e176-85.","journal-title":"Lancet HIV"},{"issue":"9","key":"key20260205164123_B13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMoa1904340","article-title":"Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1","volume":"381","author":"NAMSAL ANRS 12313 Study Group","year":"2019","unstructured":"13 NAMSAL ANRS 12313 Study Group; Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E. Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1. N Engl J Med. 2019;381(9):816-26.","journal-title":"N Engl J Med"},{"issue":"1","key":"key20260205164123_B14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12879-023-08174-3","article-title":"Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda","volume":"23","author":"Guaraldi","year":"2023","unstructured":"14 Guaraldi G, Bonfanti P, Di Biagio A, Gori A, Mili\u0107 J, Saltini P, et al. Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda. BMC Infect Dis. 2023;23(1):230.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"key20260205164123_B15","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJMra2032804","article-title":"Reassessing Human Adipose Tissue","volume":"386","author":"Cypess","year":"2022","unstructured":"15 Cypess AM. Reassessing Human Adipose Tissue. N Engl J Med. 2022; 386(8):768-79.","journal-title":"N Engl J Med"},{"issue":"2","key":"key20260205164123_B16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","unstructured":"16 Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85-97.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"key20260205164123_B17","article-title":"Exploring Visceral and Subcutaneous Adipose Tissue Secretomes in Human Obesity: Implications for Metabolic Disease","volume":"163","author":"Kahn","year":"2022","unstructured":"17 Kahn D, Macias E, Zarini S, Garfield A, Zemski Berry K, Maclean P, et al. Exploring Visceral and Subcutaneous Adipose Tissue Secretomes in Human Obesity: Implications for Metabolic Disease. Endocrinology (United States). 2022;163(11).","journal-title":"Endocrinology (United States)"},{"key":"key20260205164123_B18","first-page":"1009","volume-title":"Cardiovascular Research","author":"Guzik","year":"2017","unstructured":"18 Guzik TJ, Skiba DS, Touyz RM, Harrison DG. The role of infiltrating immune cells in dysfunctional adipose tissue. Vol. 113, Cardiovascular Research. Oxford University Press; 2017. p. 1009-23."},{"issue":"1","key":"key20260205164123_B19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","unstructured":"19 Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39-48.","journal-title":"Circulation"},{"issue":"9","key":"key20260205164123_B20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00003088-200443090-00003","article-title":"Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics","volume":"43","author":"Kearney","year":"2004","unstructured":"20 Kearney BP, Flaherty JF, Shah J. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clin Pharmacokinet. 2004;43(9):595-612.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"key20260205164123_B21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1128\/AAC.48.1.176-182.2004","article-title":"Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily","volume":"48","author":"Yuen","year":"2004","unstructured":"21 Yuen GJ, Lou Y, Bumgarner NF, Bishop JP, Smith GA, Otto VR, et al. Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily. Antimicrob Agents Chemother. 2004;48(1):176-82.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"key20260205164123_B22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1128\/AAC.01064-08","article-title":"Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir","volume":"53","author":"Pruvost","year":"2009","unstructured":"22 Pruvost A, Negredo E, Th\u00e9odoro F, Puig J, Levi M, Ayen R, et al. Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir. Antimicrob Agents Chemother. 2009;53(5):1937-43.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"key20260205164123_B23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bcp.12639","article-title":"Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients","volume":"80","author":"Zhang","year":"2015","unstructured":"23 Zhang J, Hayes S, Sadler BM, Minto I, Brandt J, Piscitelli S, et al. Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients. Br J Clin Pharmacol. 2015;80(3):502-14.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"key20260205164123_B24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1592\/phco.21.5.424.34497","article-title":"A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults","volume":"21","author":"Cr\u00e9mieux","year":"2001","unstructured":"24 Cr\u00e9mieux AC, Katlama C, Gillotin C, Demarles D, Yuen GJ, Raffi F; AZl10002 Study Group. A comparison of the steady-state pharmacokinetics and safety of abacavir, lamivudine, and zidovudine taken as a triple combination tablet and as abacavir plus a lamivudine-zidovudine double combination tablet by HIV-1-infected adults. Pharmacotherapy. 2001;21(4):424-30.","journal-title":"Pharmacotherapy"},{"key":"key20260205164123_B25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2125.2008.03132.x","article-title":"Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine\/zidovudine, and ethinyloestradiol\/levonorgestrel in healthy volunteers","volume":"65","author":"Abel","year":"2008","unstructured":"25 Abel S, Russell D, Whitlock LA, Ridgway CE, Muirhead GJ. Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine\/zidovudine, and ethinyloestradiol\/levonorgestrel in healthy volunteers. Br J Clin Pharmacol. 2008;65(Suppl 1 Suppl 1):19-26.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"key20260205164123_B26","first-page":"1931","article-title":"Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients","volume":"125","author":"Liu","year":"2012","unstructured":"26 Liu LF, Wang L, Fu Q, Zhu Z, Xie J, Han Y, et al. Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients. Chin Med J (Engl). 2012;125(11):1931-5.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"key20260205164123_B27","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3181\/0712-RM-356","article-title":"Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue","volume":"233","author":"Rebelatto","year":"2008","unstructured":"27 Rebelatto CK, Aguiar AM, Moret\u00e3o MP, Senegaglia AC, Hansen P, Barchiki F, et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood). 2008;233(7):901-13.","journal-title":"Exp Biol Med (Maywood)"},{"key":"key20260205164123_B28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-61779-367-7_14","article-title":"Culture of isolated human adipocytes and isolated adipose tissue","volume":"806","author":"Carswell","year":"2012","unstructured":"28 Carswell KA, Lee MJ, Fried SK. Culture of isolated human adipocytes and isolated adipose tissue. Methods Mol Biol. 2012;806:203-14.","journal-title":"Methods Mol Biol"},{"key":"key20260205164123_B29","volume-title":"The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro","author":"Caron","year":"2004","unstructured":"29 Caron M, Auclair M, Lagathu C, Lomb\u00e8 A, Walker UA, Kornprobst M, et al. The HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro. vol. 18. Lippincott Williams & Wilkins AIDS; 2004."},{"key":"key20260205164123_B30","doi-asserted-by":"crossref","first-page":"116010","DOI":"10.1016\/j.bcp.2023.116010","article-title":"Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function","volume":"220","author":"Quesada-L\u00f3pez","year":"2024","unstructured":"30 Quesada-L\u00f3pez T, Cereijo R, Blasco-Roset A, Mestres-Arenas A, Prieto P, Domingo JC, et al. Divergent effects of the antiretroviral drugs, dolutegravir, tenofovir alafenamide, and tenofovir disoproxil fumarate, on human adipocyte function. Biochem Pharmacol. 2024;220:116010.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"key20260205164123_B31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5501\/wjv.v6.i3.53","article-title":"Highly active antiretroviral therapy dysregulates proliferation and differentiation of human pre-adipocytes","volume":"6","author":"Jones","year":"2017","unstructured":"31 Jones E, Mazirka P, McNurlan MA, Darras F, Gelato MC, Caso G. Highly active antiretroviral therapy dysregulates proliferation and differentiation of human pre-adipocytes. World J Virol. 2017;6(3):53-8.","journal-title":"World J Virol"},{"issue":"10","key":"key20260205164123_B32","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1093\/cid\/ciaa259","article-title":"The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes","volume":"71","author":"Gorwood","year":"2020","unstructured":"32 Gorwood J, Bourgeois C, Pourcher V, Pourcher G, Charlotte F, Mantecon M, et al. The integrase inhibitors dolutegravir and raltegravir exert proadipogenic and profibrotic effects and induce insulin resistance in human\/simian adipose tissue and human adipocytes. Clin Infect Dis. 2020;71(10):e549-60.","journal-title":"Clin Infect Dis"},{"key":"key20260205164123_B33","doi-asserted-by":"crossref","first-page":"120948","DOI":"10.1016\/j.lfs.2022.120948","article-title":"Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes","volume":"308","author":"Domingo","year":"2022","unstructured":"33 Domingo P, Quesada-L\u00f3pez T, Villarroya J, Cair\u00f3 M, Gutierrez MD, Mateo MG, et al. Differential effects of dolutegravir, bictegravir and raltegravir in adipokines and inflammation markers on human adipocytes. Life Sci. 2022;308:120948.","journal-title":"Life Sci"},{"issue":"11","key":"key20260205164123_B34","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/cells11111841","article-title":"Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes","volume":"11","author":"Ngono Ayissi","year":"2022","unstructured":"34 Ngono Ayissi K, Gorwood J, Le Pelletier L, Bourgeois C, Beaup\u00e8re C, Auclair M, et al. Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes. Cells. 2022;11(11):1841.","journal-title":"Cells"},{"key":"key20260205164123_B35","first-page":"1626","volume-title":"Journal of Infectious Diseases","author":"Jung","year":"2022","unstructured":"35 Jung IR, Tu-Sekine B, Jin S, Anokye-Danso F, Ahima RS, Brown TT, et al. Dolutegravir Suppresses Thermogenesis via Disrupting Uncoupling Protein 1 Expression and Mitochondrial Function in Brown\/Beige Adipocytes in Preclinical Models. Journal of Infectious Diseases. Oxford University Press; 2022. pp. 1626-36."},{"issue":"1","key":"key20260205164123_B36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00002030-200201040-00003","article-title":"Effects of antiretroviral drug combinations on the differentiation of adipocytes","volume":"16","author":"Roche","year":"2002","unstructured":"36 Roche R, Poizot-Martin I, Yazidi CM, Compe E, Gastaut JA, Torresani J, et al. Effects of antiretroviral drug combinations on the differentiation of adipocytes. AIDS. 2002;16(1):13-20.","journal-title":"AIDS"},{"issue":"1","key":"key20260205164123_B37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/79111","article-title":"Failure of adipocyte differentiation causes type II diabetes mellitus?","volume":"26","author":"Danforth","year":"2000","unstructured":"37 Danforth E Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet. 2000;26(1):13.","journal-title":"Nat Genet"},{"issue":"1","key":"key20260205164123_B38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11154-021-09687-5","article-title":"Leptin as a key regulator of the adipose organ","volume":"23","author":"Pic\u00f3","year":"2022","unstructured":"38 Pic\u00f3 C, Palou M, Pomar CA, Rodr\u00edguez AM, Palou A. Leptin as a key regulator of the adipose organ. Rev Endocr Metab Disord. 2022;23(1):13-30.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"key20260205164123_B39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan","year":"2004","unstructured":"39 Jan V, Cervera P, Maachi M, Baudrimont M, Kim M, Vidal H, et al. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients. Antivir Ther. 2004;9(4):555-64.","journal-title":"Antivir Ther"},{"issue":"19","key":"key20260205164123_B40","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/cells11193104","article-title":"Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques","volume":"11","author":"Mausol\u00e9o","year":"2022","unstructured":"40 Mausol\u00e9o A, Olivo A, Desjardins D, S\u00e1ez-Ciri\u00f3n A, Barrail-Tran A, Avettand-Fenoel V, et al. Prolonged Antiretroviral Treatment Induces Adipose Tissue Remodelling Associated with Mild Inflammation in SIV-Infected Macaques. Cells. 2022;11(19):3104.","journal-title":"Cells"},{"issue":"1","key":"key20260205164123_B41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-009-9278-8","article-title":"Adiponectin action from head to toe","volume":"37","author":"Brochu-Gaudreau","year":"2010","unstructured":"41 Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, Palin MF. Adiponectin action from head to toe. Endocrine. 2010;37(1):11-32.","journal-title":"Endocrine"},{"issue":"2","key":"key20260205164123_B42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/QAI.0b013e31829bdb67","article-title":"Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy","volume":"64","author":"Gallego-Escuredo","year":"2013","unstructured":"42 Gallego-Escuredo JM, Villarroya J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya F, Giralt M. Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy. J Acquir Immune Defic Syndr. 2013;64(2):142-8.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"key20260205164123_B43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","unstructured":"43 Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab. 2003;88(2):627-36.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20260205164123_B44","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/jc.2002-021922","article-title":"Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"88","author":"Sutinen","year":"2003","unstructured":"44 Sutinen J, Korsheninnikova E, Funahashi T, Matsuzawa Y, Nyman T, Yki-J\u00e4rvinen H. Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J Clin Endocrinol Metab. 2003;88(4):1907-10.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20260205164123_B45","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/jac\/dkab158","article-title":"Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV","volume":"76","author":"Gonz\u00e1lez-Cord\u00f3n","year":"2021","unstructured":"45 Gonz\u00e1lez-Cord\u00f3n A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masi\u00e1 M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Mart\u00ednez E; NEAT022 Study Group. Switching from boosted PIs to dolutegravir decreases soluble CD14 and adiponectin in high cardiovascular risk people living with HIV. J Antimicrob Chemother. 2021;76(9):2380-93.","journal-title":"J Antimicrob Chemother"},{"key":"key20260205164123_B46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease","volume":"7","author":"Chait","year":"2020","unstructured":"46 Chait A, den Hartigh LJ. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front Cardiovasc Med. 2020;7:22.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"key20260205164123_B47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/dia.2014.0202","article-title":"Metabolic obesity, adipocytokines, and inflammatory markers in Asian Indians\u2014CURES-124","volume":"17","author":"Indulekha","year":"2015","unstructured":"47 Indulekha K, Surendar J, Anjana RM, Geetha L, Gokulakrishnan K, Pradeepa R, et al. Metabolic obesity, adipocytokines, and inflammatory markers in Asian Indians\u2014CURES-124. Diabetes Technol Ther. 2015;17(2):134-41.","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"key20260205164123_B48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tem.2014.02.004","article-title":"Role of interleukins in obesity: implications for metabolic disease","volume":"25","author":"Febbraio","year":"2014","unstructured":"48 Febbraio MA. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol Metab. 2014;25(6):312-9.","journal-title":"Trends Endocrinol Metab"},{"issue":"9311","key":"key20260205164123_B49","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard","year":"2002","unstructured":"49 Bastard JP, Caron M, Vidal H, Jan V, Auclair M, Vigouroux C, et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet. 2002;359(9311):1026-31.","journal-title":"Lancet"},{"key":"key20260205164123_B50","doi-asserted-by":"crossref","first-page":"670566","DOI":"10.3389\/fimmu.2021.670566","article-title":"Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment","volume":"12","author":"Bourgeois","year":"2021","unstructured":"50 Bourgeois C, Gorwood J, Olivo A, Le Pelletier L, Capeau J, Lambotte O, et al. Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment. Front Immunol. 2021;12:670566.","journal-title":"Front Immunol"},{"issue":"2","key":"key20260205164123_B51","doi-asserted-by":"crossref","first-page":"E261","DOI":"10.1152\/ajpendo.00056.2003","article-title":"Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy","volume":"286","author":"Johnson","year":"2004","unstructured":"51 Johnson JA, Albu JB, Engelson ES, Fried SK, Inada Y, Ionescu G, et al. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab. 2004;286(2):E261-71.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"9","key":"key20260205164123_B52","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1053\/meta.2002.34704","article-title":"Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy","volume":"51","author":"Hadigan","year":"2002","unstructured":"52 Hadigan C, Borgonha S, Rabe J, Young V, Grinspoon S. Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy. Metabolism. 2002;51(9):1143-7.","journal-title":"Metabolism"},{"issue":"2","key":"key20260205164123_B53","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/meta.2002.29999","article-title":"Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution","volume":"51","author":"Meininger","year":"2002","unstructured":"53 Meininger G, Hadigan C, Laposata M, Brown J, Rabe J, Louca J, et al. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism. 2002;51(2):260-6.","journal-title":"Metabolism"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T16:41:35Z","timestamp":1770309695000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/combined-tenofovir-lamivudine-and-dolutegravir-treatment-increases-leptin-and-fabp4-expression-in-human-subcutaneous-adipose-tissue\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":53,"alternative-id":["10.31744\/einstein_journal\/2026AO1770"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2026ao1770","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"eAO1770"}}